Presented on April 27, 2021 by Dr. Glen Hazlewood
Recently approved COVID-19 vaccines have brought promise to help end a pandemic that has caused an unprecedented impact on people and society. This session will review recent Canadian Rheumatology Association living guidelines on COVID-19 vaccination and emerging evidence on the safety and effectiveness of COVID-19 vaccination, as it relates to people with autoimmune rheumatic diseases. Issues of vaccine hesitancy will also be discussed.
At the end of this session, participants will be able to:
- understand the CRA Living Guideline for COVID-19 vaccination in people with autoimmune rheumatic diseases
- understand the emerging evidence on the effectiveness and safety of COVID-19 vaccines in people with autoimmune diseases
- identify factors that contribute to vaccine hesitancy and strategies on how they can be addressed
- Medical Expert
- Health Advocate
This webinar is part of a series supported by unrestricted educational grants from CRA COVID-19 Response Webinar Series supporters.